ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.80
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,181.00
      -0.88%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Precision BioSciences Inc (DTIL)

      7. Precision BioSciences Inc (DTIL) News

      DTIL

      Precision BioSciences (DTIL)

      Precision BioSciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:DTIL
      DateTimeSourceHeadlineSymbolCompany
      04/16/20244:15PMBusiness WirePrecision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail TherapeuticsNASDAQ:DTILPrecision BioSciences Inc
      03/27/20246:45AMBusiness WirePrecision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business UpdateNASDAQ:DTILPrecision BioSciences Inc
      03/20/20244:30PMBusiness WirePrecision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024NASDAQ:DTILPrecision BioSciences Inc
      03/19/20247:00AMBusiness WirePrecision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial MyopathyNASDAQ:DTILPrecision BioSciences Inc
      03/06/20248:45AMBusiness WirePrecision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC DeficiencyNASDAQ:DTILPrecision BioSciences Inc
      03/01/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
      03/01/20246:30AMBusiness WirePrecision BioSciences Announces $40.0 Million Offering of Common Stock and WarrantsNASDAQ:DTILPrecision BioSciences Inc
      03/01/20246:00AMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:DTILPrecision BioSciences Inc
      02/29/20245:19PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:DTILPrecision BioSciences Inc
      02/29/20244:01PMBusiness WirePrecision BioSciences Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:DTILPrecision BioSciences Inc
      02/20/20247:00AMBusiness WirePrecision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou BiosciencesNASDAQ:DTILPrecision BioSciences Inc
      02/14/20247:00AMBusiness WirePrecision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical ReadinessNASDAQ:DTILPrecision BioSciences Inc
      02/13/20248:29AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
      02/13/20247:00AMBusiness WirePrecision BioSciences Promotes Naresh Tanna to Vice President of Investor RelationsNASDAQ:DTILPrecision BioSciences Inc
      02/12/202411:00AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DTILPrecision BioSciences Inc
      02/12/20247:00AMBusiness WirePrecision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune DiseasesNASDAQ:DTILPrecision BioSciences Inc
      02/09/20247:00AMBusiness WirePrecision BioSciences to Effect a Reverse Stock SplitNASDAQ:DTILPrecision BioSciences Inc
      01/23/20247:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
      01/23/20247:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
      01/23/20247:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
      01/23/20247:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
      01/23/20247:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
      01/23/20245:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
      01/23/20244:27PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DTILPrecision BioSciences Inc
      01/22/20243:46PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DTILPrecision BioSciences Inc
      01/22/20243:42PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DTILPrecision BioSciences Inc
      01/22/20243:42PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DTILPrecision BioSciences Inc
      01/19/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
      01/12/20248:00AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DTILPrecision BioSciences Inc
      01/11/20248:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
       Showing the most relevant articles for your search:NASDAQ:DTIL